KING GUIDE to PARENTERAL ADMIXTURES
   
 

Setting the standard in IV drug compatibility since 1971...

 


Press Release:  December 2, 2003


 


Lexi-Comp and King Guide Publications announce relationship to enhance user experience with clinical information.  

Hudson, Ohio - Technological advances over the past several years have provided Lexi-Comp, Inc., a leading medical publisher located in Hudson, Ohio, with tremendous opportunities to transform the way healthcare providers access and utilize point-of-care drug information.  King Guide Publications, publisher of the King Guide to Parenteral Admixtures, has recently enhanced its online offering with redesigned technology and the most current knowledge in the field of drug compatibility. 

Lexi -Comp, Inc. and King Guide Publications, Inc. are pleased to announce they have agreed to a multi-year relationship that will enable subscribers of both Internet-based products to easily link between the two databases.  This agreement took effect on December 1, just in time for subscribers, and pharmacists attending the American Society of Health-System Pharmacists Midyear Clinical Meeting in New Orleans, to experience this integration. 

According to Robert Kerscher, President and CEO of Lexi-Comp, Inc., "We are very excited to be working with King Guide Publications, an industry leader in the area of compatibility content, and a high quality organization focused on enhancing patient care.  They are leading the way in supplying healthcare providers with current answers to clinical questions at the point-of-care.  Lexi-Comp’s mission is right in line with these objectives; that is, to provide practicing clinicians with the most accurate, up-to-date, concise, and clinically relevant information at the point-of-care.  Our content is updated daily and gives health care providers quick access to information that can make the practice of medicine more efficient and safer.  This relationship will enhance the user’s experience, as they will have access to both our reference content and King Guide’s compatibility information at the click of a mouse.” 

The King Guide to Parenteral Admixtures has been the standard in intravenous compatibility and stability information since 1971.  Today, pharmacists, doctors and nurses worldwide rely upon the “King Guide” to provide the most complete information available.  To keep pace with rapidly changing data, the King Guide is updated quarterly, and exceeds JCAHO expectations for up-to-date references.

With over 400 fully referenced parenteral drug monographs the King Guide is the most complete injectable drug compatibility reference available, and is also available in print, CD-ROM and PDA editions.

Lexi-Comp's commitment to excellence has allowed the publishing company to establish its position as an industry leader. Lexi-Drugs OnlineTM is utilized by thousands of healthcare providers, academicians, and students on a daily basis.  In addition, thirteen of the top seventeen outstanding medical centers mentioned in the U.S. News and World Reports 2002 Annual Honor Roll utilize Lexi-Comp's custom electronic formulary service.

Lexi-Comp, Inc., founded in 1978, was originally established to create custom reference books for clinical laboratories. Lexi-Comp has since evolved into a major reference and custom publisher with a suite of products available on many platforms, including web-based, handheld/PDA, CD-ROM, and in print. Primary areas of focus for health information content include pharmacology, diagnostic procedures and laboratory tests, natural products, dentistry, infectious diseases, and patient education. For more information, call (800) 837-5394, (330) 650-6506, or visit the Lexi-Comp web site at www.lexi.com.

King Guide Publications, Inc. was founded in 1996, and has transformed the King Guide from a print only publication to a reference for every media.  For more information, contact King Guide Publications, Inc., PO Box 10317, Napa, CA 94581, visit www.kingguide.com, or call toll-free (888)546-4484.

Spring-2008
We have added stability information for one new drug product:  PANTOPRAZOLE.  We are also reporting the results of compatibility studies for PANTOPRAZOLE in admixture with 90 parenteral products including: CASPOFUNGIN ACETATE, CIPROPLOXACIN,
ENALAPRILAT, FLUCONAZOLE, LEVOFLOXACIN, MEROPENEM, PROPOFOL, VASOPRESSIN, and ZIDOVUDINE.  Also included in the enclosed supplement is additional compatibility information for CEFTRIAXONE used with calcium-containing products.  Past Updates

Photo of a gloved hand holding a syringe

Order Form

What's New

2008 Wall Charts

2008 Concise Guide

What's Hot

Internet Edition